Recruiting Survey on Psychedelic Use and Addiction (Johns Hopkins School of Medicine)

[SteamboatBillJr]

Johns Hopkins Survey on Psychedelic Use and Addiction


Thank you for your interest in this questionnaire study on the potential relationship between psychedelic experiences and reduction or cessation of addictive behaviors. This research is being conducted by scientists at Johns Hopkins University School of Medicine and has been approved by the Johns Hopkins University Institutional Review Board (IRB). Principal Investigator: Matthew Johnson, PhD. Research Study Protocol: IRB00036856

Our Previous Research
Our research team has conducted surveys characterizing positive and challenging experiences after taking psychedelics in nonlaboratory settings, as well as instances in which taking a psychedelic was associated with a cessation or reduction in cigarette smoking. We've also studied both positive and psychologically difficult experiences, as well as headaches, after giving psilocybin to volunteers in our laboratory.

Purpose of This Study
The goal of this survey is to learn more about whether use of psychedelic drugs may be associated with reduction or cessation of addictive behaviors. We want to characterize people's experiences in non-laboratory settings in which taking a psychedelic may have led to reducing or quitting alcohol or another drug. For the purposes of this survey, we will be asking specifically about individuals who have quit or reduced using alcohol, opioids (heroin, morphine, hydrocodone, oxycodone, codeine, Oxycontin, Vicodin, Percocet, etc.), stimulants (cocaine, methamphetamine, amphetamine, methylphenidate, Adderall, Ritalin, Dexedrine, etc.), or cannabis after a psychedelic experience. For example, if you had an alcohol abuse problem that improved after a psychedelic experience, you would be a good candidate for this study. For the purposes of this survey, a psychedelic experience can refer to an experience with psilocybin (magic) mushrooms, LSD, morning glory seeds, mescaline, peyote cactus, San Pedro cactus, DMT, Ayahuasca, or MDMA (ecstasy).

Inclusion Criteria
You are invited to participate in this survey if you fulfill all of the four criteria listed below.
1) You are at least 18 years old.
2) You read and write English fluently.
3) You have taken a psychedelic drug outside of an official university or hospital study, and
4) You experienced a reduction in addictive behavior (alcohol or other drug use) after taking a psychedelic.

What the Study Entails
Participation in this study involves filling out an online survey that will take approximately 40 minutes. You will be required to complete the survey in one sitting. At the conclusion of the main survey you will be invited to participate in an optional extension of the survey that will ask some more detailed questions and take about 10 minutes to complete in addition to the main survey. These additional questions are completely optional, and you are free to accept or decline to respond to these as you choose.

Why should I participate?
We believe that this study is scientifically important. We would like you to participate because we need to collect responses from many different people. You may find this survey interesting. There is also a chance that you will be bored. Although there is no monetary compensation for participation, you will be making a unique and important contribution to science.

https://www.surveymonkey.com/r/?sm=5o7GspuA4NF70jbV3n3p8DTnoWyuZyxiss7Bs0vftN0=